Bringing the fundamentals into focus…
Back to Bicara Therapeutics Inc.
How Bicara Therapeutics Inc. stacks up
BCAX · against 471 other Healthcare companies of similar size
Profitability
17/ 100
Near the bottom of its peers.
Ranked #397 of 472 · scores higher than 15% of peers
Bars: peers in each 10-point band of the profitability score45 peers with a profitability score of 10–19, including BCAX · Click a bar to see the companies
Why profitability scores 17?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a lower return on assets: weaker than 89% of peers. Return on assets: -36.2% vs peer median 1.7%
- a lower return on invested capital: weaker than 86% of peers. Return on invested capital: -42.9% vs peer median 4.7%
- Operating margin is not reported, so it is left out of the score.
Metric by metric
Position: dot = BCAX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | BCAX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 447 reported | -42.9% | 2.4% | 13% | 33% | |
| Operating marginHigher is better · 444 reported | Not reported | 4.9% | — | — | 33% |
| Return on assetsHigher is better · 465 reported | -36.2% | 1.0% | 11% | 33% | |
| Return on equityHigher is better · 445 reported | -41.0% | 1.5% | 16% | Context only | |
| Gross marginHigher is better · 489 reported | 0.0% | 42.8% | 3% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around BCAX| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 2 | 595M USD | 99 | 97 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 578M USD | 99 | 73 | |
| 2 | 914M USD | 99 | 81 | |
| 392 | 927M USD | 18 | 41 | |
| 392 | 749M USD | 18 | 39 | |
| 392 | 994M USD | 18 | 39 | |
| 397 | 647M USD | 17 | 40 | |
| 397 | 593M USD | 17 | 40 | |
| 397 | 479M USD | 17 | 34 | |
| 397 | 393M USD | 17 | 50 | |
| 397 | 1.0B EUR (≈$1.1B) | 17 | 16 | |
| 397 | 519M USD | 17 | 22 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score